ImmunityBio
IBRX
IBRX
61 hedge funds and large institutions have $363M invested in ImmunityBio in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 59 → 61 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
61
Holding in Top 10
2
Calls
$2.83M
Puts
$1.77M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$16.4M | |
| 3 | +$12M | |
| 4 |
Goldman Sachs
New York
|
+$3.96M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$3.72M |
Top Sellers
| 1 | -$5.35M | |
| 2 | -$3.48M | |
| 3 | -$2.96M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$2.57M |
| 5 |
Morgan Stanley
New York
|
-$2.31M |